LD-2 disclosure · 4th Quarter - Report
ACADIA PHARMACEUTICALS, INC.
Client
- Name
- ACADIA PHARMACEUTICALS, INC.
- Description
- Biopharmaceutical company.
- Location
- California · United States of America
Registrant
- Description
- Government Relations.
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
2 issuesHealth Issues
Issues impacting rare disease treatments, including rare disease research incentives; H.R. 7384/S. 4583 - Creating Hope Reauthorization Act of 2024; H.R. 3433 - Give Kids a Chance Act of 2024; American Relief Act of 2025 (PL 118-158).
LobbyistsJONATHON JONES · ANDREW MCKECHNIE · BRYANT HALL · COREY MALMGREN
TargetedSENATE · HOUSE OF REPRESENTATIVES
Taxation/Internal Revenue Code
Issues related to the orphan drug tax credit.
LobbyistsJONATHON JONES · ANDREW MCKECHNIE · BRYANT HALL · COREY MALMGREN · JOHN KIRKLAND TWOMEY
Covered position (JOHN KIRKLAND TWOMEY): Chief of Staff, HHS Office of the Asst. Sec. for Legislation (2019-2021); Policy Adviser, HHS (2017-2019); Special Asst., Office of the Secretary, HHS (2017); Staff Assistant, Rep. Tom Price (2015-2017); Intern, Rep. Doug Collins (2015)
TargetedHOUSE OF REPRESENTATIVES